0001209191-19-061778.txt : 20191223 0001209191-19-061778.hdr.sgml : 20191223 20191223161140 ACCESSION NUMBER: 0001209191-19-061778 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191219 FILED AS OF DATE: 20191223 DATE AS OF CHANGE: 20191223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WOODS RANDALL E CENTRAL INDEX KEY: 0001196862 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36054 FILM NUMBER: 191306126 MAIL ADDRESS: STREET 1: C/O ARENA PHARMACEUTICALS, INC. STREET 2: 6166 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOPHIRIS BIO INC. CENTRAL INDEX KEY: 0001563855 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1258 PROSPECT STREET CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-777-1760 MAIL ADDRESS: STREET 1: 1258 PROSPECT STREET CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-19 0 0001563855 SOPHIRIS BIO INC. SPHS 0001196862 WOODS RANDALL E 1258 PROSPECT STREET LA JOLLA CA 92037 1 1 0 0 President & Chief Exec Officer Common Stock (Right to Buy) 0.36 2019-12-19 4 A 0 175000 0.36 A 2020-12-19 2029-12-18 Common Stock 175000 175000 D 33% of the shares subject to the option shall vest one year after the date of grant. The remainder shall vest monthly thereafter over the next two years until fully vested on December 19, 2022. Peter Slover, Attorney-In-Fact 2019-12-23